Acadia Healthcare Co. (NASDAQ:ACHC)’s share price was up 2.1% during mid-day trading on Monday . The company traded as high as $54.85 and last traded at $54.27, with a volume of 556,519 shares trading hands. The stock had previously closed at $53.15.

A number of equities analysts recently issued reports on ACHC shares. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a report on Tuesday, April 19th. Jefferies Group reiterated a “buy” rating and issued a $85.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 22nd. Mizuho boosted their price objective on Acadia Healthcare from $66.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, April 29th. Robert W. Baird reiterated a “buy” rating on shares of Acadia Healthcare in a research note on Monday, May 16th. Finally, Leerink Swann reiterated an “outperform” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Friday. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and ten have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $79.33.

The firm has a market capitalization of $4.76 billion and a PE ratio of 32.40. The stock has a 50-day moving average of $57.51 and a 200-day moving average of $57.64.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Thursday, April 28th. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.01. The business had revenue of $616.80 million for the quarter, compared to analyst estimates of $612.77 million. During the same quarter last year, the business earned $0.43 EPS. Acadia Healthcare’s revenue for the quarter was up 68.6% compared to the same quarter last year. On average, equities analysts expect that Acadia Healthcare Co. will post $2.83 EPS for the current fiscal year.

A number of large investors have modified their holdings of ACHC. Wells Fargo & Company MN raised its stake in shares of Acadia Healthcare by 51.3% in the fourth quarter. Wells Fargo & Company MN now owns 4,329,117 shares of the company’s stock worth $270,397,000 after buying an additional 1,468,501 shares during the period. Jennison Associates LLC raised its stake in shares of Acadia Healthcare by 40.1% in the fourth quarter. Jennison Associates LLC now owns 1,280,675 shares of the company’s stock worth $79,991,000 after buying an additional 366,545 shares during the period. Monarch Partners Asset Management LLC raised its stake in shares of Acadia Healthcare by 76.1% in the fourth quarter. Monarch Partners Asset Management LLC now owns 355,284 shares of the company’s stock worth $22,191,000 after buying an additional 153,535 shares during the period. Bank of Montreal Can raised its stake in shares of Acadia Healthcare by 17.6% in the fourth quarter. Bank of Montreal Can now owns 349,672 shares of the company’s stock worth $21,841,000 after buying an additional 52,353 shares during the period. Finally, Century Capital Management LLC raised its stake in shares of Acadia Healthcare by 1.4% in the fourth quarter. Century Capital Management LLC now owns 300,988 shares of the company’s stock worth $18,800,000 after buying an additional 4,293 shares during the period.

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The Company develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.